Literature DB >> 19299129

Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.

Daniele Castagnolo1, Marco Radi, Filippo Dessì, Fabrizio Manetti, Manuela Saddi, Rita Meleddu, Alessandro De Logu, Maurizio Botta.   

Abstract

A series of novel enantiomerically pure azole derivatives was synthesized. The new compounds, bearing both an imidazole as well as a triazole moiety, were evaluated as antimycobacterial agents. One of them proved to have activity against Mycobaterium tuberculosis comparable to those of the classical antibacterial/antifungal drugs Econazole and Clotrimazole.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299129     DOI: 10.1016/j.bmcl.2009.02.101

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  An enlarged, adaptable active site in CYP164 family P450 enzymes, the sole P450 in Mycobacterium leprae.

Authors:  Christopher R J Agnew; Andrew G S Warrilow; Nicholas M Burton; David C Lamb; Steven L Kelly; R Leo Brady
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

2.  Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis.

Authors:  Giovanna Poce; Sara Consalvi; Giulia Venditti; Salvatore Alfonso; Nicoletta Desideri; Raquel Fernandez-Menendez; Robert H Bates; Lluis Ballell; David Barros Aguirre; Joaquin Rullas; Alessandro De Logu; Michelle Gardner; Thomas R Ioerger; Eric J Rubin; Mariangela Biava
Journal:  ACS Med Chem Lett       Date:  2019-09-18       Impact factor: 4.345

Review 3.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

4.  Novel Thiazolidinone-Azole Hybrids: Design, Synthesis and Antimycobacterial Activity Studies.

Authors:  Barbaros Eroglu; Keriman Ozadali-Sari; Oya Unsal-Tan; Sriram Dharmarajan; Perumal Yogeeswari; Ayla Balkan
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Chemoenzymatic synthesis and biological evaluation of enantiomerically enriched 1-(β-hydroxypropyl)imidazolium- and triazolium-based ionic liquids.

Authors:  Paweł Borowiecki; Małgorzata Milner-Krawczyk; Jan Plenkiewicz
Journal:  Beilstein J Org Chem       Date:  2013-03-12       Impact factor: 2.883

6.  Synthesis of Novel Fluorene Bisamide Derivatives via Ugi Reaction and Evaluation their Biological Activity against Mycobacterium species.

Authors:  Ali Hossein Rezayan; Safoura Hariri; Parisa Azerang; Ghazaleh Ghavami; Isabel Portugal; Soroush Sardari
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.